HomeCompareKBYPF vs MO

KBYPF vs MO: Dividend Comparison 2026

KBYPF yields 1.97% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $25.8K in total portfolio value· pulled ahead in Year 7
10 years
KBYPF
KBYPF
● Live price
1.97%
Share price
$34.05
Annual div
$0.67
5Y div CAGR
39.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.3K
Annual income
$11,659.32
Full KBYPF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — KBYPF vs MO

📍 MO pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKBYPFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KBYPF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KBYPF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBYPF
Annual income on $10K today (after 15% tax)
$167.25/yr
After 10yr DRIP, annual income (after tax)
$9,910.42/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MO beats the other by $15,724.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBYPF + MO for your $10,000?

KBYPF: 50%MO: 50%
100% MO50/50100% KBYPF
Portfolio after 10yr
$67.2K
Annual income
$20,909.24/yr
Blended yield
31.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

KBYPF
No analyst data
Altman Z
6.0
Piotroski
2/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBYPF buys
0
MO buys
0
No recent congressional trades found for KBYPF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKBYPFMO
Forward yield1.97%6.36%
Annual dividend / share$0.67$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR39.2%22.6%
Portfolio after 10y$54.3K$80.1K
Annual income after 10y$11,659.32$30,159.17
Total dividends collected$30.6K$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: KBYPF vs MO ($10,000, DRIP)

YearKBYPF PortfolioKBYPF Income/yrMO PortfolioMO Income/yrGap
1$10,974$273.90$10,570$780.30+$404.00KBYPF
2$12,133$391.03$11,381$1,032.90+$752.00KBYPF
3$13,545$562.44$12,535$1,392.73+$1.0KKBYPF
4$15,310$816.84$14,193$1,920.91+$1.1KKBYPF
5$17,583$1,201.13$16,618$2,723.68+$965.00KBYPF
6$20,608$1,794.56$20,263$3,993.80+$345.00KBYPF
7← crossover$24,787$2,736.31$25,936$6,098.36$1.1KMO
8$30,804$4,281.61$35,166$9,775.01$4.4KMO
9$39,882$6,922.17$51,026$16,597.78$11.1KMO
10$54,333$11,659.32$80,113$30,159.17$25.8KMO

KBYPF vs MO: Complete Analysis 2026

KBYPFStock

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, household products, skincare, and body warmers. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eyebon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods. Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Full KBYPF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this KBYPF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBYPF vs SCHDKBYPF vs JEPIKBYPF vs OKBYPF vs KOKBYPF vs MAINKBYPF vs PMKBYPF vs BTIKBYPF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.